Preventing multiple sclerosis?

G C Ebers¹

Affiliations

Comment

G C Ebers. Lancet. 2001.

. 2001 May 19;357(9268):1547.

doi: 10.1016/S0140-6736(00)04778-4.

G C Ebers¹

¹ Department of Clinical Neurology, University of Oxford, Radcliffe Infirmary, OX2 CH2, Oxford, UK. george.ebers@clinical-neurology.oxford.ac.uk

No abstract available

Comment on

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.
Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernández O, Hartung H, Seeldrayers P, Sørensen PS, Rovaris M, Martinelli V, Hommes OR; Early Treatment of Multiple Sclerosis Study Group. Comi G, et al. Lancet. 2001 May 19;357(9268):1576-82. doi: 10.1016/s0140-6736(00)04725-5. Lancet. 2001. PMID: 11377645 Clinical Trial.